Industry Research Reports
Home > Reports > Chemical & Material > Global Human Chorionic Gonadotropin Market Research Report 2025
Global Human Chorionic Gonadotropin Market Research Report 2025
Industry: Chemical & Material
Published Date: 2025-02-24
Pages: 64 Pages
Report ld: 4204940
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Chorionic Gonadotropin Market Size(US$)
CAGR 2025-2031
8.1%
Market Size,2031
USD 3,765
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,358 million
Market Forecast in 2031(Value)
US$ 3,765 million
CAGR
8.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Human Chorionic Gonadotropin was valued at US$ 2197 million in the year 2024 and is projected to reach a revised size of US$ 3765 million by 2031, growing at a CAGR of 8.1% during the forecast period.
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men.
This report aims to provide a comprehensive presentation of the global market for Human Chorionic Gonadotropin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Chorionic Gonadotropin.
The Human Chorionic Gonadotropin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Chorionic Gonadotropin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Chorionic Gonadotropin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- Bristol Myers Squibb
- Merck & Co
- Ferring
- Fresenius Kabi
- Sun Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural Source Extraction
- Recombinant Technology
Segment by Application
- Fertility Clinics
- Research Institutions
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Chorionic Gonadotropin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Chorionic Gonadotropin Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Natural Source Extraction
1.2.3 Recombinant Technology
1.3 Market by Application
1.3.1 Global Human Chorionic Gonadotropin Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Fertility Clinics
1.3.3 Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Chorionic Gonadotropin Market Perspective (2020-2031)
2.2 Global Human Chorionic Gonadotropin Growth Trends by Region
2.2.1 Global Human Chorionic Gonadotropin Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Chorionic Gonadotropin Historic Market Size by Region (2020-2025)
2.2.3 Human Chorionic Gonadotropin Forecasted Market Size by Region (2026-2031)
2.3 Human Chorionic Gonadotropin Market Dynamics
2.3.1 Human Chorionic Gonadotropin Industry Trends
2.3.2 Human Chorionic Gonadotropin Market Drivers
2.3.3 Human Chorionic Gonadotropin Market Challenges
2.3.4 Human Chorionic Gonadotropin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Chorionic Gonadotropin Players by Revenue
3.1.1 Global Top Human Chorionic Gonadotropin Players by Revenue (2020-2025)
3.1.2 Global Human Chorionic Gonadotropin Revenue Market Share by Players (2020-2025)
3.2 Global Human Chorionic Gonadotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Chorionic Gonadotropin Revenue
3.4 Global Human Chorionic Gonadotropin Market Concentration Ratio
3.4.1 Global Human Chorionic Gonadotropin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Chorionic Gonadotropin Revenue in 2024
3.5 Global Key Players of Human Chorionic Gonadotropin Head office and Area Served
3.6 Global Key Players of Human Chorionic Gonadotropin, Product and Application
3.7 Global Key Players of Human Chorionic Gonadotropin, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Chorionic Gonadotropin Breakdown Data by Type
4.1 Global Human Chorionic Gonadotropin Historic Market Size by Type (2020-2025)
4.2 Global Human Chorionic Gonadotropin Forecasted Market Size by Type (2026-2031)
5 Human Chorionic Gonadotropin Breakdown Data by Application
5.1 Global Human Chorionic Gonadotropin Historic Market Size by Application (2020-2025)
5.2 Global Human Chorionic Gonadotropin Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Chorionic Gonadotropin Market Size (2020-2031)
6.2 North America Human Chorionic Gonadotropin Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Chorionic Gonadotropin Market Size by Country (2020-2025)
6.4 North America Human Chorionic Gonadotropin Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Chorionic Gonadotropin Market Size (2020-2031)
7.2 Europe Human Chorionic Gonadotropin Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Chorionic Gonadotropin Market Size by Country (2020-2025)
7.4 Europe Human Chorionic Gonadotropin Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Chorionic Gonadotropin Market Size (2020-2031)
8.2 Asia-Pacific Human Chorionic Gonadotropin Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Chorionic Gonadotropin Market Size (2020-2031)
9.2 Latin America Human Chorionic Gonadotropin Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Chorionic Gonadotropin Market Size by Country (2020-2025)
9.4 Latin America Human Chorionic Gonadotropin Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Chorionic Gonadotropin Market Size (2020-2031)
10.2 Middle East & Africa Human Chorionic Gonadotropin Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Details
11.1.2 Bristol Myers Squibb Business Overview
11.1.3 Bristol Myers Squibb Human Chorionic Gonadotropin Introduction
11.1.4 Bristol Myers Squibb Revenue in Human Chorionic Gonadotropin Business (2020-2025)
11.1.5 Bristol Myers Squibb Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Human Chorionic Gonadotropin Introduction
11.2.4 Merck & Co Revenue in Human Chorionic Gonadotropin Business (2020-2025)
11.2.5 Merck & Co Recent Development
11.3 Ferring
11.3.1 Ferring Company Details
11.3.2 Ferring Business Overview
11.3.3 Ferring Human Chorionic Gonadotropin Introduction
11.3.4 Ferring Revenue in Human Chorionic Gonadotropin Business (2020-2025)
11.3.5 Ferring Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Details
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Human Chorionic Gonadotropin Introduction
11.4.4 Fresenius Kabi Revenue in Human Chorionic Gonadotropin Business (2020-2025)
11.4.5 Fresenius Kabi Recent Development
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Details
11.5.2 Sun Pharmaceutical Business Overview
11.5.3 Sun Pharmaceutical Human Chorionic Gonadotropin Introduction
11.5.4 Sun Pharmaceutical Revenue in Human Chorionic Gonadotropin Business (2020-2025)
11.5.5 Sun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Human Chorionic Gonadotropin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Natural Source Extraction
Table 3. Key Players of Recombinant Technology
Table 4. Global Human Chorionic Gonadotropin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Human Chorionic Gonadotropin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Human Chorionic Gonadotropin Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Human Chorionic Gonadotropin Market Share by Region (2020-2025)
Table 8. Global Human Chorionic Gonadotropin Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Human Chorionic Gonadotropin Market Share by Region (2026-2031)
Table 10. Human Chorionic Gonadotropin Market Trends
Table 11. Human Chorionic Gonadotropin Market Drivers
Table 12. Human Chorionic Gonadotropin Market Challenges
Table 13. Human Chorionic Gonadotropin Market Restraints
Table 14. Global Human Chorionic Gonadotropin Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Human Chorionic Gonadotropin Market Share by Players (2020-2025)
Table 16. Global Top Human Chorionic Gonadotropin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin as of 2024)
Table 17. Ranking of Global Top Human Chorionic Gonadotropin Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Human Chorionic Gonadotropin Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Human Chorionic Gonadotropin, Headquarters and Area Served
Table 20. Global Key Players of Human Chorionic Gonadotropin, Product and Application
Table 21. Global Key Players of Human Chorionic Gonadotropin, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Chorionic Gonadotropin Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Human Chorionic Gonadotropin Revenue Market Share by Type (2020-2025)
Table 25. Global Human Chorionic Gonadotropin Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Human Chorionic Gonadotropin Revenue Market Share by Type (2026-2031)
Table 27. Global Human Chorionic Gonadotropin Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Human Chorionic Gonadotropin Revenue Market Share by Application (2020-2025)
Table 29. Global Human Chorionic Gonadotropin Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Human Chorionic Gonadotropin Revenue Market Share by Application (2026-2031)
Table 31. North America Human Chorionic Gonadotropin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Human Chorionic Gonadotropin Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Human Chorionic Gonadotropin Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Human Chorionic Gonadotropin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Human Chorionic Gonadotropin Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Human Chorionic Gonadotropin Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Human Chorionic Gonadotropin Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Chorionic Gonadotropin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Human Chorionic Gonadotropin Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Human Chorionic Gonadotropin Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Human Chorionic Gonadotropin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bristol Myers Squibb Company Details
Table 47. Bristol Myers Squibb Business Overview
Table 48. Bristol Myers Squibb Human Chorionic Gonadotropin Product
Table 49. Bristol Myers Squibb Revenue in Human Chorionic Gonadotropin Business (2020-2025) & (US$ Million)
Table 50. Bristol Myers Squibb Recent Development
Table 51. Merck & Co Company Details
Table 52. Merck & Co Business Overview
Table 53. Merck & Co Human Chorionic Gonadotropin Product
Table 54. Merck & Co Revenue in Human Chorionic Gonadotropin Business (2020-2025) & (US$ Million)
Table 55. Merck & Co Recent Development
Table 56. Ferring Company Details
Table 57. Ferring Business Overview
Table 58. Ferring Human Chorionic Gonadotropin Product
Table 59. Ferring Revenue in Human Chorionic Gonadotropin Business (2020-2025) & (US$ Million)
Table 60. Ferring Recent Development
Table 61. Fresenius Kabi Company Details
Table 62. Fresenius Kabi Business Overview
Table 63. Fresenius Kabi Human Chorionic Gonadotropin Product
Table 64. Fresenius Kabi Revenue in Human Chorionic Gonadotropin Business (2020-2025) & (US$ Million)
Table 65. Fresenius Kabi Recent Development
Table 66. Sun Pharmaceutical Company Details
Table 67. Sun Pharmaceutical Business Overview
Table 68. Sun Pharmaceutical Human Chorionic Gonadotropin Product
Table 69. Sun Pharmaceutical Revenue in Human Chorionic Gonadotropin Business (2020-2025) & (US$ Million)
Table 70. Sun Pharmaceutical Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
Table 74. Authors List of This Report
List of Figures
Figure 1. Human Chorionic Gonadotropin Picture
Figure 2. Global Human Chorionic Gonadotropin Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Chorionic Gonadotropin Market Share by Type: 2024 VS 2031
Figure 4. Natural Source Extraction Features
Figure 5. Recombinant Technology Features
Figure 6. Global Human Chorionic Gonadotropin Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Chorionic Gonadotropin Market Share by Application: 2024 VS 2031
Figure 8. Fertility Clinics Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. Human Chorionic Gonadotropin Report Years Considered
Figure 12. Global Human Chorionic Gonadotropin Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Human Chorionic Gonadotropin Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Chorionic Gonadotropin Market Share by Region: 2024 VS 2031
Figure 15. Global Human Chorionic Gonadotropin Market Share by Players in 2024
Figure 16. Global Top Human Chorionic Gonadotropin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Human Chorionic Gonadotropin Revenue in 2024
Figure 18. North America Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Human Chorionic Gonadotropin Market Share by Country (2020-2031)
Figure 20. United States Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Human Chorionic Gonadotropin Market Share by Country (2020-2031)
Figure 24. Germany Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Human Chorionic Gonadotropin Market Share by Region (2020-2031)
Figure 32. China Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Human Chorionic Gonadotropin Market Share by Country (2020-2031)
Figure 40. Mexico Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Human Chorionic Gonadotropin Market Share by Country (2020-2031)
Figure 44. Turkey Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Human Chorionic Gonadotropin Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bristol Myers Squibb Revenue Growth Rate in Human Chorionic Gonadotropin Business (2020-2025)
Figure 48. Merck & Co Revenue Growth Rate in Human Chorionic Gonadotropin Business (2020-2025)
Figure 49. Ferring Revenue Growth Rate in Human Chorionic Gonadotropin Business (2020-2025)
Figure 50. Fresenius Kabi Revenue Growth Rate in Human Chorionic Gonadotropin Business (2020-2025)
Figure 51. Sun Pharmaceutical Revenue Growth Rate in Human Chorionic Gonadotropin Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 8.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Human Chorionic Gonadotropin market?
What was the global market size of Human Chorionic Gonadotropin in 2025?
What is the annual compound growth rate of the global Human Chorionic Gonadotropin market size from 2025 to 2031?
What was the global market size of Human Chorionic Gonadotropin in 2031?
Related Reports
Human Chorionic Gonadotropin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Chorionic Gonadotropin was estimated to be worth US$ 2358 million in 2025 and is projected to reach US$ 4039 million, growing at a CAGR of 8.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 98
USD 3950.00
(Single User License)
Global Human Chorionic Gonadotropin Market Research Report 2026
The global Human Chorionic Gonadotropin market was valued at US$ 2358 million in 2025 and is anticipated to reach US$ 4039 million by 2032, at a CAGR of 8.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 100
USD 2900.00
(Single User License)
Global Human Chorionic Gonadotropin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Chorionic Gonadotropin market is projected to grow from US$ 2197 million in 2024 to US$ 3765 million by 2031, at a CAGR of 8.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-26
Pages: 113
USD 4900.00
(Single User License)
Global Human Chorionic Gonadotropin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Chorionic Gonadotropin market size was US$ 2197 million in 2024 and is forecast to a readjusted size of US$ 3765 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 73
USD 4250.00
(Single User License)
Human Chorionic Gonadotropin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Chorionic Gonadotropin was estimated to be worth US$ 2197 million in 2024 and is forecast to a readjusted size of US$ 3765 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 75
USD 3950.00
(Single User License)
Global Human Chorionic Gonadotropin Market Insights, Forecast to 2030
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
Published Date: 2024-04-12
Pages: 92
USD 4900.00
(Single User License)
Human Chorionic Gonadotropin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
Published Date: 2024-01-24
Pages: 82
USD 3950.00
(Single User License)
Global Human Chorionic Gonadotropin Market Research Report 2024
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
Published Date: 2024-01-16
Pages: 70
USD 2900.00
(Single User License)
Human Chorionic Gonadotropin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Chorionic Gonadotropin was estimated to be worth US$ 2358 million in 2025 and is projected to reach US$ 4039 million, growing at a CAGR of 8.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 98
USD 3950.00 (Single User License)Global Human Chorionic Gonadotropin Market Research Report 2026
The global Human Chorionic Gonadotropin market was valued at US$ 2358 million in 2025 and is anticipated to reach US$ 4039 million by 2032, at a CAGR of 8.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 100
USD 2900.00 (Single User License)Global Human Chorionic Gonadotropin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Chorionic Gonadotropin market is projected to grow from US$ 2197 million in 2024 to US$ 3765 million by 2031, at a CAGR of 8.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-26
Pages: 113
USD 4900.00 (Single User License)Global Human Chorionic Gonadotropin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Chorionic Gonadotropin market size was US$ 2197 million in 2024 and is forecast to a readjusted size of US$ 3765 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 73
USD 4250.00 (Single User License)Human Chorionic Gonadotropin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Chorionic Gonadotropin was estimated to be worth US$ 2197 million in 2024 and is forecast to a readjusted size of US$ 3765 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 75
USD 3950.00 (Single User License)Global Human Chorionic Gonadotropin Market Insights, Forecast to 2030
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
Published: 2024-04-12
Pages: 92
USD 4900.00 (Single User License)Human Chorionic Gonadotropin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
Published: 2024-01-24
Pages: 82
USD 3950.00 (Single User License)Global Human Chorionic Gonadotropin Market Research Report 2024
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
Published: 2024-01-16
Pages: 70
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now